Change search criteria ↓

Search results

1 384 projects found matching your search criteria:

  1. 1. Effect of continuous renal replacement therapy with regional citrate anticoagulation on the concentrations of most commo…

    Principal investigator: Ilona Nowak-Kózka

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Lekarski

    Call: PRELUDIUM 8, Panel: NZ5

  2. 2. Next-Generation Exosome Therapy: Engineering NK Cell-Derived Vesicles for Targeted Cancer Treatment

    Principal investigator: dr Daria Nawrocka

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

    Call: SONATINA 9, Panel: NZ6

  3. 3. Silicon and titanium as beam-activated tumour tracers for online proton therapy monitoring

    Principal investigator: Magdalena Maria Kołodziej

    Uniwersytet Jagielloński, Wydział Fizyki, Astronomii i Informatyki Stosowanej

    Call: PRELUDIUM 22, Panel: ST2

  4. 4. New approach to glioblastoma adoptive therapy based on inducible CAR expression system - SynCAR

    Principal investigator: dr hab. Radosław Zagożdżon

    Warszawski Uniwersytet Medyczny

    Call: OPUS 29, Panel: NZ6

  5. 5. Efficiency biomarkers in photodynamic therapy against lung cancer

    Principal investigator: dr Martyna Krzykawska-Serda

    Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

    Call: PRELUDIUM 2, Panel: NZ4

  6. 6. Where Inhibition is not Enough- Development of Innovative Compounds for Targeted Degradation of Extracellular and Membra…

    Principal investigator: dr Marcin Skoreński

    Politechnika Wrocławska

    Call: OPUS 28 (LAP), Panel: NZ5

  7. 7. Hybrid Nanocomposites Based on Gold Nanoparticles as Promising Photoactive Materials for Combined Photothermal/Photodyna…

    Principal investigator: dr Paulina Błaszkiewicz

    Uniwersytet im. Adama Mickiewicza w Poznaniu, Centrum NanoBioMedyczne

    Call: SONATINA 7, Panel: ST4

  8. 8. Liposomal theranostic agent for magnetic resonance imaging and photodynamic therapy

    Principal investigator: dr Paulina Krystyna Skupin-Mrugalska

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny

    Call: SONATA 11, Panel: NZ7

  9. 9. Synthesis of new phthalocyanines for targeted photodynamic cancer therapy.

    Principal investigator: dr Łukasz Andrzej Łapok

    Uniwersytet Jagielloński, Wydział Chemii; Zespół Nanotechnologii Polimerów i Biomateriałów

    Call: SONATA 2, Panel: ST5

  10. 10. Dual cell cycle blockade and immune checkpoint inhibition as a potential strategy of sequential anticancer therapy

    Principal investigator: Alicja Stanisława Słota

    Uniwersytet Jagielloński

    Call: PRELUDIUM 24, Panel: NZ7

  11. 11. Personalized selective activation of γδT Vδ2 cells using zoledronic acid for glioblastoma MICA/Bhigh therapy: in vitro a…

    Principal investigator: Natalia Anna Lehman

    Uniwersytet Medyczny w Lublinie

    Call: PRELUDIUM 24, Panel: NZ4

  12. 12. Perinuclear AKAP6 signalosome as a new target for gene therapy in ischemic optic neuropathy

    Principal investigator: dr hab. Tomasz Boczek

    Uniwersytet Medyczny w Łodzi, Wydział Nauk o Zdrowiu

    Call: OPUS 22, Panel: NZ4

  13. 13. New approach for neuronal regeneration and survival following ischemic stroke - gene therapy based on MEF2A repression u…

    Principal investigator: dr Malwina Anna Lisek

    Uniwersytet Medyczny w Łodzi, Wydział Nauk o Zdrowiu

    Call: SONATA 16, Panel: NZ4

  14. 14. Glycoconjugated zinc phthalocyanine as a novel photodynamic therapy tool for the treatment of psoriasis

    Principal investigator: prof. Piotr Paweł Ziółkowski

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej

    Call: PRELUDIUM BIS 1, Panel: NZ4

  15. 15. The EBI2 receptor/oxysterol signalling in multiple sclerosis pathophysiology, therapy and diagnostics.

    Principal investigator: dr Aleksandra Rutkowska

    Gdański Uniwersytet Medyczny, Wydział Lekarski

    Call: OPUS 17, Panel: NZ4

  16. 16. Adeno-associated virus (AAV)-based gene therapy in the regeneration of optic nerve after ischemic stroke.

    Principal investigator: dr hab. Tomasz Boczek

    Uniwersytet Medyczny w Łodzi, Wydział Nauk o Zdrowiu

    Call: OPUS 17, Panel: NZ4

  17. 17. Development of the novel experimental gene therapy approach for glaucoma treatment - focusing on the role of RNA-binding…

    Principal investigator: dr Adrian Smędowski

    Śląski Uniwersytet Medyczny w Katowicach, Wydział Nauk Medycznych w Katowicach

    Call: SONATA 13, Panel: NZ4

  18. 18. Mesenchymal stromal cells (MSC) as carriers of IL-12 cDNA in treatment of mice with melanoma B16-F10 and metastases

    Principal investigator: Natalia Iwona Kułach

    Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie, Oddział w Gliwicach

    Call: PRELUDIUM 9, Panel: NZ4

  19. 19. Regulation of ALKBH proteins expression in cancer and its role in cancer therapy.

    Principal investigator: prof. Elżbieta Grzesiuk

    Instytut Biochemii i Biofizyki PAN

    Call: OPUS 2, Panel: NZ4

  20. 20. Modulations of DNA repair induced by anti cancer drugs by thiosugars

    Principal investigator: dr hab. Tomasz Popławski

    Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

    Call: OPUS 1, Panel: NZ4

  21. 21. Iron chelators- the novel approach to anticancer therapy

    Principal investigator: Maciej Michał Serda

    UNIWERSYTET ŚLĄSKI, Wydział Matematyki Fizyki i Chemii

    Call: PRELUDIUM 1, Panel: NZ4

  22. 22. Development of Red-Emitting Chiral Carbon Dots for Advanced Photodynamic Therapy (PDT)

    Principal investigator: Patryk Szymaszek

    Politechnika Krakowska im. Tadeusza Kościuszki

    Call: PRELUDIUM 24, Panel: ST8

  23. 23. Synergistic enhancement of reactive oxygen species generation via combination of heavy atom effect with donor-acceptor a…

    Principal investigator: Karolina Anna Urbanowicz

    Politechnika Warszawska

    Call: PRELUDIUM 24, Panel: ST5

  24. 24. Simulation of complex biological systems assisted by artificial intelligence: language-controlled model for cancer thera…

    Principal investigator: prof. Witold Dzwinel

    Akademia Górniczo-Hutnicza im. Stanisława Staszica w Krakowie

    Call: OPUS 29, Panel: ST6

  25. 25. Molecular Pathogenesis and Precision Antisense Oligonucleotide Therapy for BAG3-Related Myofibrillar Myopathy Type 6 Usi…

    Principal investigator: dr Estera Elmira Rintz

    Uniwersytet Gdański

    Call: OPUS 29, Panel: NZ2

  26. 26. Elimination of IgE-producing cells using next-generation chimeric antigen receptor (CAR)-based therapy

    Principal investigator: dr hab. Beata Kaleta

    Warszawski Uniwersytet Medyczny

    Call: OPUS 29, Panel: NZ6

  27. 27. Photoactive, supramolecular, and biocompatible materials suitable for antimicrobial photodynamic therapy

    Principal investigator: dr Dorota Anna Chełminiak-Dudkiewicz

    Uniwersytet Mikołaja Kopernika

    Call: WEAVE-UNISONO, Panel: ST5

  28. 28. New violacein derivatives as candidates for sonodynamic therapy against skin cancer

    Principal investigator: dr Daniel Ryszard Ziental

    Uniwersytet Przyrodniczy w Poznaniu

    Call: SONATINA 9, Panel: NZ7

  29. 29. The role of EZH2 activity in the development of resistance to targeted therapy in melanoma

    Principal investigator: dr Michał Jerzy Woźniak

    Uniwersytet Medyczny w Łodzi

    Call: OPUS 28, Panel: NZ7

  30. 30. Environmental modulation of CDK4/6 inhibitor efficacy: Impact of mycotoxin alternariol exposure on anti-cancer therapies

    Principal investigator: dr Anna Dominika Walczak-Szeffer

    Uniwersytet Medyczny w Łodzi

    Call: SONATA 20, Panel: NZ5

  31. 31. Synthesis of novel hybrid nanomaterials based on fullerene scaffold for photodynamic therapy of cancer

    Principal investigator: Dominik Jakub Dreszer

    UNIWERSYTET ŚLĄSKI

    Call: PRELUDIUM 23, Panel: NZ7

  32. 32. Precision double strike against non-small cell lung cancer. Insights into multidirectional therapies and the landscape o…

    Principal investigator: dr Katarzyna Anna Malarz

    Politechnika Śląska

    Call: OPUS 27, Panel: NZ5

  33. 33. Identification and characterization of omics profiles in patients' serum during anti-CD19 CAR-T cell therapy

    Principal investigator: Jaromir Bartosz Tomasik

    Warszawski Uniwersytet Medyczny

    Call: PRELUDIUM 23, Panel: NZ5

  34. 34. Development and characterization of novel multitargeted organometallic tubulin polymerization inhibitors for enhancing t…

    Principal investigator: dr hab. Damian Nestor Plażuk

    Uniwersytet Łódzki

    Call: OPUS 27, Panel: NZ7

  35. 35. Miniature CRISPR/Cas nucleases for upregulation of utrophin expression: a novel approach for mutation-independent therap…

    Principal investigator: prof. Józef Dulak

    Uniwersytet Jagielloński

    Call: DAINA 3, Panel: NZ3

  36. 36. LighTEM - light-induced in situ electron microscopy and its application in the imaging of light-matter interactions on t…

    Principal investigator: dr hab. Andrzej Marek Żak

    Politechnika Wrocławska

    Call: SONATA 19, Panel: ST11

  37. 37. Synthesis, characterization, and evaluation of the biological activity of innovative thermosensitive suppositories compr…

    Principal investigator: prof. Ewa Olędzka

    Warszawski Uniwersytet Medyczny, Wydział Farmaceutyczny

    Call: OPUS 26, Panel: NZ7

  38. 38. Prioritizing diagnostics and therapeutics of human prion diseases through integrative omics

    Principal investigator: prof. Beata Katarzyna Sikorska

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

    Call: JPND Call 2023, Panel: NZ2

  39. 39. Anticancer potential of TMPyP4 porphyrin in breast cancer photodynamic therapy and evaluation of the treatment safety

    Principal investigator: prof. Błażej Rubiś

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

    Call: OPUS 25, Panel: NZ7

  40. 40. Targeting Energy Metabolism for Precision Cancer Therapy: Novel Inhibitors of LDH-A and PDK1 as Potential Strategies to …

    Principal investigator: Marika Anna Frańczak

    Gdański Uniwersytet Medyczny, Wydział Lekarski

    Call: PRELUDIUM 22, Panel: NZ7

  41. 41. Unveiling the molecular signature underlying resistance to CD19 CAR-T therapy in malignant cells.

    Principal investigator: Marta Krawczyk

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

    Call: PRELUDIUM 22, Panel: NZ7

  42. 42. Effect of the chronic treatment with lamotrigine on changes in expression of genes related to seizure processes in the s…

    Principal investigator: prof. Kinga Katarzyna Borowicz

    Uniwersytet Medyczny w Lublinie, Wydział Farmaceutyczny

    Call: PRELUDIUM BIS 4, Panel: NZ7

  43. 43. Research on the preparation of new, hydrogel nanosystems for targeted therapy of colorectal cancer

    Principal investigator: dr Urszula Helena Piotrowska

    Warszawski Uniwersytet Medyczny

    Call: SONATA 18, Panel: NZ7

  44. 44. Investigating the role of fibroblast growth factor receptors and STAT transcription factors in the targeted therapy of a…

    Principal investigator: prof. Ewa Teresa Marcinkowska

    Uniwersytet Wrocławski, Wydział Biotechnologii

    Call: PRELUDIUM BIS 4, Panel: NZ5

  45. 45. Molecular insights into hypoxic tumors – for development of targeted cancer therapeutics

    Principal investigator: dr Marco Deiana

    Politechnika Wrocławska

    Call: POLONEZ BIS 3, Panel: NZ5

  46. 46. Pancreatic cancer oxygenation as a prognostic marker during anticancer therapy

    Principal investigator: dr Martyna Krzykawska-Serda

    Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

    Call: OPUS 23, Panel: NZ5

  47. 47. Phagocytic cells as boron carriers in boron neutron capture therapy

    Principal investigator: Anna Maria Rudawska

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

    Call: PRELUDIUM 21, Panel: NZ5

  48. 48. Modulation of HIV-1 epitranscriptome: A novel approach to improve "shock & kill" therapy.

    Principal investigator: Haider Ali brak danych (PI has only a Name - in accordance with PESEL)

    Uniwersytet Jagielloński, Małopolskie Centrum Biotechnologii Uniwersytetu Jagiellońskiego

    Call: PRELUDIUM 21, Panel: NZ6

  49. 49. Bioconjugates of 103Pd nanostructures for targeted Auger electron therapy.

    Principal investigator: dr hab. Agnieszka Majkowska-Pilip

    Instytut Chemii i Techniki Jądrowej

    Call: OPUS 23, Panel: ST5

  50. 50. Gold nanoparticles functionalized with zinc(II) dipyrromethene and azadipyrromethene complexes as new approach in photod…

    Principal investigator: dr Ewelina Wieczorek-Szweda

    Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Chemii

    Call: SONATINA 6, Panel: ST4

Graphic design and implementation: Jakub Piotrowski